Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• The dopamine transporter (DAT) regulates dopamine (DA) levels and is critical for dopaminergic neurotransmission.
• Dysregulation of DAT is linked to various neurological and psychiatric disorders.
• Palmitoylation, a lipid modification, was previously shown to regulate DAT activity and expression.

Purpose of the Study:

• To investigate the mechanisms and outcomes of increased DAT palmitoylation.
• To identify specific palmitoyl acyltransferases (PATs) that regulate DAT palmitoylation.
• To understand how enhanced palmitoylation affects DAT function and stability.

Main Methods:

• Co-expression of DAT with various PATs (DHHC enzymes).
• Assessment of DAT palmitoylation levels at Cys580.
• Measurement of DAT transport kinetics and expression levels.
• Analysis of DAT degradation rates.

Main Results:

• Specific PATs (DHHC2, DHHC3, DHHC8, DHHC15, DHHC17) were found to stimulate DAT palmitoylation.
• Increased palmitoylation at Cys580 led to enhanced DAT transport kinetics.
• Elevated DAT expression was observed due to reduced transporter degradation.
• These findings highlight palmitoylation as a key regulator of DAT properties.

Conclusions:

• Palmitoylation is a critical regulator of DAT function, expression, and stability.
• Specific PATs play a significant role in modulating DAT activity.
• Defects in palmitoylation pathways may contribute to dopamine transporter imbalances in DA disorders.